The new funding supports clinical trials as well as preclinical work to identify biomarkers of therapeutic response.
The program will provide two young scientists with funding for independent research as well as resources to help them commercialize their technology.
A pilot program will allow 100 individuals and families with a rare form of epilepsy to receive exome sequencing as part of a larger epilepsy genetics database effort.
In his report, President Trump called for a reduction in National Institutes of Health funding, along with a reorganization of the agency.
The funding builds on more than $1.7 million already awarded to the firm, which is building a diagnostic for characterizing patients in clinical trials.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.